Inhibitory actions of ellagic acid on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients

Microbios

Volumn 93, Issue 375, 1998, Pages 115-127

  Chung, Jing G ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ellagic acid; Helicobacter pylori; N acetyltransferase

Indexed keywords

2 FLUORENYLAMINE; 2-AMINOFLUORENE; 4 AMINOBENZOIC ACID; ACETYL COENZYME A; ARYLAMINE ACETYLTRANSFERASE; BACTERIAL PROTEIN; ELLAGIC ACID; FLUORENE DERIVATIVE; MUTAGENIC AGENT; SUNSCREEN;

ARTICLE; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; MICROBIOLOGY; PEPTIC ULCER; TIME;

4-AMINOBENZOIC ACID; ACETYL COENZYME A; ARYLAMINE N-ACETYLTRANSFERASE; BACTERIAL PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; ELLAGIC ACID; FLUORENES; HELICOBACTER PYLORI; HUMANS; MUTAGENS; PEPTIC ULCER; SUNSCREENING AGENTS; TIME FACTORS;

EID: 0031634905     PISSN: 00262633     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AHN D., Puto D., Kresty L., Stoner G. D., Fromm D. and Hollenberg F. 1996. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzyme. Carcinogenesis 17 821-8
2. AKAGI K., Hirose M., Hosgiya T., Mizoguchi Y, Ito N. and Shirai T. 1995. Modulating effects of ellagic acid, vanillin and quercetin in rat medium term multi-organ carcinogenesis model. Cancer Letters 94 113-21.
3. ARYTON A. D., Lewis D. F. V., Walker R. and Ionnides C. 1992. Antimutagenicity of ellagic acid towards the food mutagen IQ: investigation into possible mechanisms of action. Fd Chem. Toxicol. 30 289-95.
4. BARCH D. H. and Fox C. C. 1988. Selective inhibition of methylbenzyl- nitrosamine-induced formation of esophageal o6-methylguanine by dietary ellagic acid in rats. Cancer Res. 48 7088-92.
5. BARCH D. H. and Fox C. C. 1989. Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. Cancer Letters 44 39-44.
6. BELL D. A., Badawi A. F., Lang N. P., IIett K. F., Kadlubar F. F. and Hirvonen A. 1995. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissues. Cancer Res. 55 5226-9.
7. BRADFORD M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72 248-54.
8. CARTWRIGHT R. A., Glasham R. W., Rogers H. J., Ahmad R. A., Barham-Hall D., Higgins E. M. A. and Kaha M. A. 1982. The role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiolpgical approach to bladder cancer. Lancet 2 842-6.
9. CHUNG J. G., Wang H. H., Tsou M. F., Hsien S. E., Lo H. H., Yen Y. S., Chang S. S., Wu L. T., Lee J. H. and Hung C. F. 1997. Evidence for arylamine N-acetyltransferase in the bacteria Helicobacter pylori. Toxicol. Letters 91 63-71.
10. CLELAND W. W. 1967. The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29 1-30.
11. CORREA R 1992. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res. 52 6735-40.
12. COVER T. L. and Blaser M. J. 1992. Helicobacter pylori and gastroduodenal disease. A. Rev. Med. 43 135-45.
13. DAS M., Bickers D. R. and Mukhtar H. 1985. Effects of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies in the mechanism of its anticarcinogenic action. Carcinogenesis 6 1409-13.
14. DIXON M. F. 1989. Campylobacter pylori and chronic gastritis. In Campylobacter pylori and Gastroduodenal Disease. pp 106-16. Blackwell Scientific Publications, Oxford.
15. EINISTO P., Watanabe M., Ishidate M. and Nohmi T. 1991. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res. 259 95-102.
16. GALI H. U., Perchellet E. M. and Perchellet J. P. 1991. Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. Cancer Res. 51 2820-5.
17. IIETT K. K., David B. M., Detchon P., Castledon W. M. and Kwa R. 1982. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47 1466-9.
18. KATO J., Tominaga S. and lto Y. 1992. A prospective study of atrophic gastritis and stomach cancer risk. Jpn. J. Cancer Res. 83 1137-42.
19. LANG N. P., Chu D. Z. J., Hunter C. F., Kendell D. C., Flammang J. J. and Kadlubar F. 1987. Role of aromatic amine acetyltransferase in human colorectal cancer. Archs Surg. 121 1259-61.
20. MAJID S. M., Khanduja K. L., Gandhi R. K., Kapur S. and Sharma R. R. 1991. Influence of ellagic acid on antioxidant defense system and lipid peroxidation in mice. Biochem. Pharmacol. 42 1441-5.
21. MANDAL S. and Stoner G. D. 1990. Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11 55-61.
22. MARSHALL B. 1986. Campylobacter pylori and gastritis. J. infect. Dis. 153 650-7.
23. MARSHALL B., Goodfwin C. S. and Warren J. R. 1988. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Cancer Res. 2 1437-47.
24. PARKER H. G. and Evans A. E. J. 1984. Epidemiology of aromatic amine cancers. In Chemical Carcinogens. Vol 182, pp 277-302. Edited by C. E. Searle. American Chemical Society Monograph, Washington, D.C., U.S.A.
25. ROBERT-THOMSON I. C., Ryan P., Khoo K. K., Hart W. J., McMichael A. J. and Bulter R. N. 1996. Diet, acetylator phenotype, and risk of colorectal neoplasm. Lancet 347 1372-4.
26. SMART R. C., Huang M. T., Chang R. L., Sayer J. M., Young B. and Guzelian P. S. 1986. Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3′-di-O-methylellagic acid in mice. Carcinogenesis 7 1663-7.
27. STONER G. D. and Mukhtar H. 1995. Polyphenols as cancer chemopreventive agents. J. Cell Biochem. (Suppl) 22 169-80.
28. TANAKA T., Iwata H., Niwa K., Mori Y. and Mori H. 1988. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male AVI/N rats. Jpn. J. Cancer Res. 79 1297-303.
29. WANG H. H. and Chung J. G. 1997. Emodin-induced inhibition of growth and DNA damage in Helicobacter pylori. Curr. Microbiol. 35 262-6.
30. WEBER W. W. and Hein D. W. 1985. N-acetylation pharmacogenetics. Pharm. Rev. 37 25-79.